ClinicalTrials.gg
CompletedNCT07261943Updated Dec 3, 2025

The Effect of Sexual Counseling Based on the BETTER Model on Sexual Function and Quality of Sexual Life in Postmenopausal Women

An interventional study of The group that received sexual education based on the BETTER model in Sexual Behavior, Climactericum and Sexuality Education, sponsored by Karamanoğlu Mehmetbey University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 41 Years to 64 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-03.

Primary conditionSexualityRegistry: Sexual BehaviorReclassifiedWhy we changed it
Registry
Sexual Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Sexuality
Why
  1. The study's listed conditions name Sexuality, a narrower term within Sexual Behavior.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Karamanoğlu Mehmetbey University · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 7 months after the study started (first participant enrolled Feb 2024, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Non-randomized
Ages
41 Years to 64 Years
Sex
Female
01

Study summary

Sexual life, an integral part of overall health, remains one of the most neglected, undervalued, and problematic areas within today's healthcare system Various management strategies exist for managing sexual dysfunction, including behavioral, psychological, and pharmacological strategies, and researchers have used education and counseling interventions for this purpose. One such intervention is the BETTER model, which aims to collaborate with individuals experiencing sexual difficulties to address their problems. Discussing sexuality with individuals experiencing sexual difficulties and providing counseling services will significantly benefit healthcare professionals in promoting safe sexual practices, identifying existing or potential sexual problems, and addressing these issues

02

Conditions studied

  • Sexual Behavior
  • Climactericum
  • Sexuality Education

Browse trials for

Keywords

  • BETTER model
  • sexuality
  • sexual education
03

In context

Sexuality Reclassified

130 studies on the registry are indexed under Sexuality; 26 are open to participants now.

This study's enrollment of 90 is above the median of 75 across 79 interventional studies indexed under Sexuality.

Browse Sexuality studies →

Lead sponsor

Karamanoğlu Mehmetbey University is the lead sponsor of 69 studies on the registry; 19 are open to participants now.

Compared within Sexuality, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Sexual Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
41 Years to 64 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women who are married, sexually active, and have a regular sexual life
  • Who are literate
  • Who are (the time period between one year after menopause and old age within the WHO's definition of postmenopause)
  • Who are more than one year postmenopause
  • Who are not over 65 years of age, which is considered the age limit by the WHO -Who agree to participate in the study
  • Who have entered menopause naturally-Who have scored ≤26.55 on the FSFI scale

Exclusion criteria

Exclusion Criteria:

  • Being on Hormone Replacement Therapy (HRT) and not having stopped at least six months before the study
  • Having entered early menopause (before the age of 40)
  • Having a chronic systemic disease and/or a psychiatric health problem
  • Having a disability that makes communication difficult, such as hearing or language impairment
  • Having received any sexual education before or during the study
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Postmenopausal

Periods have stopped for good: usually no period for 12 months in a row without another medical reason, sometimes confirmed by a blood test (FSH).

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (actual)

Study arms

  • No intervention
    control group
  • Experimental
    experimental group

    The group that received sexual education based on the BETTER model

    Other: The group that received sexual education based on the BETTER model

Interventions

  • OtherThe group that received sexual education based on the BETTER model

    The women in the experimental group will be trained in groups of 5-6, in a designated classroom in the Department of Obstetrics and Gynecology at the relevant hospital, in four sessions, each lasting 45-60 minutes, with a one-week break. The training will utilize warm-up exercises, PowerPoint presentations, question-and-answer sessions, and discussions. All women in the training group will be given the opportunity to ask questions and express themselves. Evaluation of the training will be conducted through Q\&A and verbal feedback from the women, and further training will be provided on the requested topics based on their questions.No intervention will be made to the women in the control group after the pre-tests.

06

What researchers measure

Primary outcomes

  1. Measuring the impact of sexual counseling based on the BETTER model

    After sexual counseling based on the BETTER model, the Female Sexual Function Index (FSFI) scale were administered to women in the experimental and control groups via face-to-face interviews. The administration time for each scale varied between 15 and 20 minutes. Changes in the Female Sexual Function Index (FSFI) scale were measured two months after sexual counseling based on the BETTER model. Female Sexual Function Index (FSFI) It was developed by Rosen et al. as a multidimensional scale comprising 19 items to evaluate female sexual function. The scale includes six subheadings, desire, arousal, lubrication, orgasm, satisfaction, and pain. Each title was scored between 0 or 1 and six. The lowest and highest scores are 2 and 36, respectively. Higher scores indicated better sexual function. The cut-off value of the scale was 26.55. A total FSFI score of ≤26.55, it indicates sexual dysfunction

    Time frame: two months

Secondary outcomes

  1. Measuring the impact of sexual counseling based on the BETTER model

    After sexual counseling based on the BETTER model, the Sexual Quality of Life-Female (SQoL-F) scale were administered to women in the experimental and control groups via face-to-face interviews. The administration time for each scale varied between 15 and 20 minutes. Changes in the Female Sexual Quality of Life (SQoL-F) scales were measured two months after sexual counseling based on the BETTER model. Sexual Quality of Life-Female (SQoL-F): Developed by Symonds et al., with Turkish validity and reliability conducted by Tuğut and Gölbaşı. It is a 6-point Likert-type scale with 18 items. Respondents consider their sexual life over the past four weeks. Scores range from 18 to 108. Higher scores indicate better sexual quality of life.

    Time frame: two months

07

Study locations

1 site
  • Karamanoglu Mehmetbey University
    Karaman, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2024 to primary completion in May 2025, 15 months.

Of 54 non-industry interventional studies with no phase under Sexuality, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 32. This study's 15 months is above that.

Counting every sponsor, half of 54 studies reached it within 12 months; a quarter within 6 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 22, 2025
First posted
Dec 3, 2025
StartActual
Feb 12, 2024
Primary completionActual
May 15, 2025
CompletionActual
Sep 12, 2025
Last update
Dec 3, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 3, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07261943
Lead sponsor
Karamanoğlu Mehmetbey University
Responsible party
Serap Kırıcı (Lecturer, Karamanoğlu Mehmetbey University) — Principal investigator
First posted
Dec 3, 2025
Start date
Feb 12, 2024
Primary completion
May 15, 2025
Completion
Sep 12, 2025
Last update
Dec 3, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion